XLE off 4%, Nasdaq off 1.57%

After Close: Financials and Materials also hit hard, down over 2%

Biotech stocks remain a safe harbor in a stormy market freaked out by the energy free-fall. Most major biotech ETFs are up (FBT, XBI) but the IBB was a little volatile, eventually off 0.16%.

Kite Pharma (KITE) took its symbol cue and was up 15%. With the JPMorgan Healthcare Conference beginning on January 12 there will be further news to support the sector.

Large Cap Biotech: GILD up 2.23%, FBT up 0.45%, REGN up 0.84%, RHHBY up 0.44%.